Cancer Vaccines
Phase I Trial for ImmunoCellular Therapeutics Brain Tumor Vaccine Commences
Published in Gene Therapy Weekly, May 24th, 2007
The vaccine trial, which is being conducted at the newly dedicated Johnny L. Cochran, Jr. Brain Tumor Center at Cedars-Sinai Medical Center in Los Angeles, is being funded by IMUC and is designed to evaluate safety/toxicity, feasibility and biological activity. The trial should also provide a preliminary indication of whether the vaccine is generating an immune response in patients, one of the necessary preconditions to the vaccine being effective. Approximately 30 patients are expected to be enrolled in the trial, which...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-05-24)
More Articles from Gene Therapy Weekly
- Breast Cancer
Molecules with Potential to Treat Breast Cancer Found - Gene Therapy
Dealing Deadly Cancers a Knockout Punch - Ovarian Cancer
Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer - Bioterrorism
AVI BioPharma Receives DoD Contracts for Bioterrorism Response Therapies - Gene Therapy
Altus Pharmaceuticals Inititates Phase III Clinical Trials of ALTU-135 for Cystic Fibrosis Patients with Pancreatic Insufficiency - Gene Therapy
CEO of World's First Profitable Regenerative Medicine Company, ORGANOGENESIS, Details Path to Profitability for the Regenerative Medicine Field - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
